Anti-Mullerian hormone, traditionally thought of as a passive byproduct of polycystic ovary syndrome, may actually play an active role in the disorder, according to new research.
When we think of having our own handy multi-purpose robots, we tend to picture something out of Star Wars or The Jetsons — but the useful technology of the ‘future’ may not be as far off as we think. Maria Bauza Villalonga, PhD student at MIT, hosted a Seminar @ Cornell Tech to show how robots can become our best allies.
Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.
Powering augmented and virtual reality technologies to tackle real-world problems is the focus of a two-year, $1.8 million grant from Meta and Spark AR to Cornell Bowers CIS and Cornell Tech’s XR Collaboratory.
Cornell researchers have created the most advanced virtual reality urban farm tour ever made, an online learning experience that promises to transport urban and rural farmers to New York City’s Red Hook Farms without ever leaving home.
A Cornell Tech clinic has created a new approach to helping survivors of domestic abuse stop assailants from hacking into their devices and social media to surveil and harass them.
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.
Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.
